je.st
news
Tag: merck
Merck drug extends immune system fight to stomach cancer
2014-09-28 15:10:51| Biotech - Topix.net
Merck & Co's drug Keytruda, the first in a new wave of immune-boosting medicines to be approved for treating melanomas in the United States, also has potential in stomach cancer, new research shows. Early clinical trial results reported on Sunday mean that gastric, or stomach cancer can be added to a growing list of tumor types where so-called immunotherapy may have an important role to play.
Tags: system
drug
fight
cancer
Merck Announces First Presentation of Data on the Investigational Use of KEYTRUDA (pembrolizumab) in Patients with Advanced Gastric Cancer at ESMO 2014
2014-09-28 09:15:00| Merck.com - Corporate News
Dateline City: WHITEHOUSE STATION, N.J. KEYTRUDA monotherapy achieved 31 percent overall response rate in patients with PD-L1 positive, advanced gastric cancer Phase 2 study to be initiated in first quarter of 2015 (KEYNOTE-059) WHITEHOUSE STATION, N.J.--(BUSINESS WIRE)--Merck (NYSE:MRK), known as MSD outside the United States and Canada, today announced the first presentation of data on the investigational use of KEYTRUDA (pembrolizumab) the companys anti-PD-1 therapy in PD-L1 positive, advanced gastric cancer. The early findings presented showed an overall response rate (confirmed and unconfirmed) of 31 percent with KEYTRUDA as monotherapy, as measured by investigator assessed, RECIST v1.1 (n= 12/39: 95% CI, 17-47). Language: English Contact: MerckMedia:Ian McConnell, 973-901-5722orClaire Mulhearn, 908-423-7425orInvestor:Joseph Romanelli, 908-423-5185orJustin Holko, 908-423-5088 Ticker Slug: Ticker: MRK Exchange: NYSE read more
Tags: with
data
advanced
presentation
Merck KGaA To Buy Sigma-Aldrich
2014-09-26 05:43:07| Chemicals - Topix.net
Sigma-Aldrich has agreed to be acquired by Germany's Merck for $17.0 billion. The deal will join two of the largest suppliers of laboratory chemicals and ingredients for drug manufacturing into a business with more than 300,000 products, 2 million customers, and annual sales of more than $6 billion.
Tags: buy
merck
kgaa
merck kgaa
Merck to Hold Third-Quarter 2014 Sales and Earnings Conference Call on October 27
2014-09-24 23:00:00| Merck.com - Corporate News
Dateline City: WHITEHOUSE STATION, N.J. WHITEHOUSE STATION, N.J.--(BUSINESS WIRE)--Merck (NYSE: MRK), known as MSD outside the United States and Canada, will hold its third-quarter 2014 sales and earnings conference call with institutional investors and analysts at 8:00 a.m. EDT on Monday, Oct. 27. During the call, company executives will provide an overview of Mercks performance for the quarter. Language: English Contact: MerckMedia:Lainie Keller, 908-423-4187Steven Cragle, 908-423-3461orInvestor:Justin Holko, 908-423-5088Joe Romanelli, 908-423-5185 Ticker Slug: Ticker: MRK Exchange: NYSE read more
German Merck to buy St. Louis-based Sigma-Aldrich
2014-09-22 15:41:56| Biotech - Topix.net
German drug company Merck says it has agreed to buy St. Louis-based chemical firm Sigma-Aldrich Corp. for $17 billion in a deal Merck says will strengthen its business in chemicals and laboratory equipment. Darmstadt-based Merck KGaA said Monday it is paying $140 per share in cash for all of Sigma-Aldrich's shares - a premium of 37 percent over Friday's closing price of $102.37.
Tags: buy
german
merck
sigmaaldrich
Sites : [69] [70] [71] [72] [73] [74] [75] [76] [77] [78] [79] [80] [81] [82] [83] [84] [85] [86] [87] [88] next »